Scarica l'app Stockscreener
6.40
1.08%
-0.07
Dopo l'orario di chiusura:
6.40
Precedente Chiudi:
$6.47
Aprire:
$6.45
Volume 24 ore:
322.24K
Relative Volume:
0.76
Capitalizzazione di mercato:
$424.69M
Reddito:
$555.06M
Utile/perdita netta:
$-39.48M
Rapporto P/E:
-10.67
EPS:
-0.6
Flusso di cassa netto:
$29.05M
1 W Prestazione:
-1.39%
1M Prestazione:
-5.33%
6M Prestazione:
-36.19%
1 anno Prestazione:
-14.21%
Intervallo 1D:
$6.37
$6.505
Intervallo di 1 settimana:
$6.26
$6.59
Portata 52W:
$6.02
$14.38
Bioventus Inc Stock (BVS) Company Profile
Nome
Bioventus Inc
Settore
Industria
Telefono
(919) 474-6700
Indirizzo
4721 EMPEROR BOULEVARD, SUITE 100, DURHAM
Confronta BVS con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
BVS
Bioventus Inc
|
6.40 | 427.34M | 555.06M | -39.48M | 29.05M | -0.60 |
|
ABT
Abbott Laboratories
|
125.64 | 218.92B | 43.11B | 13.98B | 6.66B | 7.98 |
|
BSX
Boston Scientific Corp
|
106.21 | 152.62B | 17.55B | 2.03B | 2.72B | 1.37 |
|
SYK
Stryker Corp
|
396.66 | 153.22B | 23.22B | 2.86B | 3.58B | 7.40 |
|
MDT
Medtronic Plc
|
92.32 | 117.89B | 33.54B | 4.66B | 5.19B | 3.62 |
|
EW
Edwards Lifesciences Corp
|
75.80 | 45.12B | 5.54B | 4.18B | 623.10M | 7.00 |
Bioventus Inc Stock (BVS) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-07-07 | Iniziato | Cantor Fitzgerald | Overweight |
| 2024-12-17 | Aggiornamento | JP Morgan | Underweight → Neutral |
| 2023-12-07 | Aggiornamento | Canaccord Genuity | Hold → Buy |
| 2023-08-09 | Aggiornamento | Craig Hallum | Hold → Buy |
| 2022-11-22 | Downgrade | Craig Hallum | Buy → Hold |
| 2022-11-09 | Downgrade | Canaccord Genuity | Buy → Hold |
| 2022-11-09 | Downgrade | JP Morgan | Overweight → Underweight |
| 2022-03-15 | Iniziato | Craig Hallum | Buy |
| 2021-11-15 | Ripresa | Morgan Stanley | Overweight |
| 2021-11-10 | Ripresa | JP Morgan | Overweight |
| 2021-07-01 | Downgrade | Goldman | Buy → Neutral |
| 2021-03-08 | Iniziato | Canaccord Genuity | Buy |
| 2021-03-08 | Iniziato | Goldman | Buy |
| 2021-03-08 | Iniziato | JP Morgan | Overweight |
| 2021-03-08 | Iniziato | Morgan Stanley | Overweight |
Mostra tutto
Bioventus Inc Borsa (BVS) Ultime notizie
Is Bioventus Inc. a good long term investmentHigh-octane gains - jammulinksnews.com
Bioventus Inc. Stock Analysis and ForecastExplosive earning power - jammulinksnews.com
What analysts say about Bioventus Inc. stockExplosive market performance - Autocar Professional
What drives Bioventus Inc. stock priceAccelerated wealth building - jammulinksnews.com
Bioventus (NASDAQ:BVS) Cut to “Buy” at Wall Street Zen - Defense World
Cantor Fitzgerald Initiates Coverage of Bioventus (BVS) with an Overweight Rating - MSN
Bioventus (NASDAQ:BVS) Downgraded to Buy Rating by Wall Street Zen - MarketBeat
Analysts Expect Bioventus Inc. (NASDAQ:BVS) To Breakeven Soon - simplywall.st
What makes Bioventus Inc. stock price move sharplyFree Best Performing Stock Alerts - beatles.ru
why bioventus inc. stock attracts strong analyst attentionWeekly Big Movers - newser.com
How Bioventus Inc. stock performs during market volatilityBreakout Momentum Stocks - beatles.ru
Why Bioventus Inc. stock attracts strong analyst attentionFree Stock Market Strategy Classes - Newser
10 Undervalued Medical Device Stocks to Buy Now - Insider Monkey
Allspring Global Investments Holdings LLC Raises Stock Holdings in Bioventus Inc. (NYSE:BVS) - Defense World
With 36% stake, Bioventus Inc. (NASDAQ:BVS) seems to have captured institutional investors' interest - Yahoo Finance
How the (BVS) price action is used to our Advantage - news.stocktradersdaily.com
Bioventus(BVS) Shares Soar 3.54% on Pipeline Progress - AInvest
Cantor Fitzgerald Initiates Coverage on Bioventus (NYSE:BVS) - Defense World
Cantor Fitzgerald initiates Bioventus stock with Overweight rating on growth potential By Investing.com - Investing.com South Africa
Cantor Fitzgerald initiates Bioventus stock with Overweight rating on growth potential - Investing.com Nigeria
Cartilage Repair Regeneration Market is Going To Boom | Zimmer Biomet, Bioventus - newstrail.com
Bioventus' Bold Bet on Core Markets: A Strategic Shift With High Stakes - AInvest
BVS: Riding the Market Waves of Growth and Decline in 2023 - investchronicle.com
(BVS) Technical Pivots with Risk Controls - news.stocktradersdaily.com
Do Options Traders Know Something About Bioventus Stock We Don't? - The Globe and Mail
(BVS) Proactive Strategies - news.stocktradersdaily.com
Bone Growth Stimulator Market Booming Worldwide with - openPR.com
Bioventus Inc Azioni (BVS) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
0.03%
0.79%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):